Posted by Michael Wonder on 19 Jul 2021
Nevro announces FDA approval of its 10 kHz high frequency spinal cord stimulation therapy for treatment of chronic pain associated with painful diabetic neuropathy
19 July 2021 - HFX for painful diabetic neuropathy now the only spinal cord stimulation system approved by FDA to treat painful diabetic neuropathy.
Nevro today announced receipt of FDA approval of its Senza system for the treatment of chronic pain associated with painful diabetic neuropathy.
